Drug Delivery

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

Research sheds new light on cancer risk in gene therapies

How virus-based cancer therapeutic strategies could increase treatment efficacy

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond